ATS Corporation delivers global automation solutions, designing, building, and servicing manufacturing systems for multinational customers. It focuses on life sciences, food & beverage, and energy markets, which now represent over 85% of its substantial backlog. The company helps clients enhance efficiency and solve complex production challenges, while executing a cost transformation program for margin improvement.
Key Inputs And Sourcing
1. Components (Electronic & Mechanical)
Not in registry
component · Global (e.g., Hong Kong S.A.R., Germany, Thailand, China) · unknown
Source ATS designs and builds complex automation systems and robotics, relying heavily on components like robots, lasers, pneumatic valves, electrical connectors, motors, and hardware.
Confidence: high
2. Labor (Skilled Engineers & Technicians)
Matched (medium)engine_advertising_brand_tracking · access=file · map_only
labor · Global (e.g., North America, Europe, Southeast Asia, Oceania) · unknown
Source Custom automation solutions are highly labor-intensive, requiring skilled engineers and technicians for design, development, manufacturing, and after-sales services. Labor is explicitly mentioned as a component of COGS.
Confidence: high
3. Raw Materials (Steel & Aluminum)
Not in registry
commodity · steel · Global · unknown
Source As a manufacturer of industrial machinery and automation systems, structural metals like steel and aluminum are fundamental inputs. Rapid changes in raw material costs can impact profitability.
Confidence: medium
4. Energy (Electricity & Natural Gas)
Not in registry
energy · natural-gas · Local to manufacturing facilities (e.g., Canada, Europe, US) · unknown
Source Manufacturing facilities and the operation of complex machinery consume significant energy. Utilities and facility costs are part of COGS.
Confidence: medium
5. Software & Control Systems
Not in registry
component · Global · unknown
Source Modern automation systems rely heavily on specialized software, programmable logic controllers (PLCs), SCADA, and other control systems. ATS partners with major providers like Siemens and Rockwell Automation.
Confidence: medium
6. Logistics/Freight
Not in registry
logistics · Global · unknown
Source ATS operates globally, shipping components from various origins (e.g., Hong Kong S.A.R., Germany, Thailand, China) and delivering large, complex automation systems worldwide.
Confidence: medium
7. Specialized Materials (e.g., for containment, cleanrooms)
Not in registry
other · Global · unknown
Source For its life sciences (radiopharma, sterile filling) and nuclear segments, ATS requires specialized materials for containment, cleanroom environments, and radiation shielding.
Confidence: low
8. Packaging Materials (for equipment shipment)
Not in registry
packaging · Regional/Global · unknown
Source ATS manufactures and ships large, complex equipment, requiring robust packaging materials to protect systems during transit. The company's packaging automation business also involves packaging-related inputs.
Confidence: low
Industry Publications
- BioProcess International (bioprocessintl.com) — Provides premier technical coverage of biopharmaceutical development, manufacturing, sterile fill-finish, and scale-up, directly relevant to ATS's life sciences automation solutions for pharma and radiopharma.
- Fierce Pharma (fiercepharma.com) — Offers comprehensive reporting on commercial pharmaceutical supply agreements, CDMO capacity, and industry news, which impacts ATS's clients in the life sciences and pharmaceutical automation sectors.
- Industrial Machinery Digest (industrialmachinerydigest.com) — Serves as an extensive publication for the industrial machinery industry, covering new products, solutions, and trends that are crucial for monitoring ATS's core business of designing and building factory automation systems.
- Packaging Digest (packagingdigest.com) — Focuses on news, trends, and automation solutions within the packaging industry, which is a significant segment for ATS, particularly with its packaging automation equipment.
- Manufacturing Journal (manufacturing-journal.net) — Delivers international manufacturing news, industry insights, and expert articles for industrial decision-makers, providing a broad perspective on automation trends and the global manufacturing landscape relevant to ATS's diverse customer base.
Economic Data Watch
1. FRED — Industrial Production and Capacity Utilization
Matchedfred · access=api · map_only
Metric/field INDPRO
Cadence monthly
Why it matters Industrial production is a broad indicator of manufacturing activity, directly impacting the demand for ATS's automation solutions across its industrial and consumer segments.
Signal to watch Increasing industrial production indicates a stronger demand environment for automation equipment and services.
Confidence: high
2. Trading Economics — Economic Indicators
Not in registryaccess=scrape
Metric/field Germany Industrial Production
Cadence monthly
Why it matters ATS has significant operations and is undergoing fixed cost transformation in Europe, making Germany's industrial production a key regional economic indicator for its business.
Signal to watch Growth in German industrial production suggests improved business conditions and potential for increased capital expenditure in a key European market.
Confidence: high
3. IQVIA, EvaluatePharma, Company Earnings Reports — Pharmaceutical Sales Data
Matchediqvia_prescription_rx_data · access=file · map_only
Metric/field Global GLP-1 Drug Sales Growth (Year-over-Year)
Cadence quarterly
Why it matters GLP-1 related activity is a significant driver for ATS's Life Sciences segment, with substantial backlog and future growth potential in peptide manufacturing and fill-finish automation.
Signal to watch Sustained double-digit growth in global GLP-1 drug sales indicates strong market adoption and continued demand for ATS's specialized automation solutions.
Confidence: medium
4. FRED — Construction Spending
Matchedconstruction_total · access=api
Metric/field TTLCONS
Cadence monthly
Why it matters Total construction spending is relevant for ATS's energy segment, particularly for new power generation facilities (e.g., data centers, nuclear plants) and new factory builds in other segments.
Signal to watch Rising construction spending suggests increased capital investment in infrastructure and manufacturing facilities, creating opportunities for ATS.
Confidence: high
5. Trading Economics — Economic Indicators
Not in registryaccess=scrape
Metric/field Canada Business Confidence
Cadence monthly
Why it matters As a Canadian-headquartered company, overall business confidence in Canada can influence domestic capital expenditure decisions and the broader economic sentiment impacting ATS's operations.
Signal to watch Improving business confidence in Canada indicates a more favorable environment for investment and expansion, potentially leading to increased automation project demand.
Confidence: high
Free Alt Data Watch
1. ClinicalTrials.gov — Study Records
Not in registry
Metric/field Number of new studies initiated (status 'Not yet recruiting' or 'Recruiting') for 'GLP-1' OR 'peptide' OR 'obesity'
Cadence daily
Why it matters Indicates the expanding pipeline and R&D activity in key therapeutic areas, driving future demand for manufacturing automation in life sciences.
Signal to watch An increasing number of new clinical trials suggests a robust and growing pipeline for GLP-1 and peptide-based therapies, signaling future manufacturing capacity needs.
Confidence: high
2. U.S. Nuclear Regulatory Commission (NRC) — Reactor License Applications and Approvals
Not in registry
Metric/field Number of new Small Modular Reactor (SMR) or large reactor license applications/approvals
Cadence irregular
Why it matters ATS's nuclear business, particularly in SMRs and large reactors, is a significant growth area. Regulatory approvals are critical precursors to project awards and revenue generation.
Signal to watch An increase in new license applications or approvals for SMRs and large reactors indicates progress in the nuclear market, creating potential project opportunities for ATS.
Confidence: high
3. USASpending.gov — Federal Contract Awards
Not in registryaccess=api
Metric/field Total contract obligations for 'ATS Corporation' or 'ATS Automation Tooling Systems Inc.'
Cadence daily
Why it matters ATS serves regulated markets like nuclear and life sciences, which may involve government contracts. Tracking these awards provides direct insight into new business wins.
Signal to watch An increase in federal contract awards to ATS suggests new business opportunities and validation of its capabilities in regulated sectors.
Confidence: high
4. ATS Corporation Careers Page — Job Postings
Matched (medium)engine_advertising_brand_tracking · access=file · map_only
Metric/field Total number of open job postings, filtered by 'Life Sciences', 'Nuclear', 'Automation Engineer'
Cadence weekly
Why it matters Hiring trends, especially in key growth areas like life sciences and nuclear, can signal internal investment, expansion, or the ramp-up of new projects.
Signal to watch An increasing number of job postings, particularly for specialized roles in growth segments, indicates strategic investment and anticipated project activity.
Confidence: high
5. Google Trends — Search Interest
Not in registry
Metric/field Search interest for 'radiopharma automation'
Cadence daily
Why it matters Radiopharma is a standout performer and a key growth area for ATS. Tracking search interest provides a proxy for broader market attention and potential demand.
Signal to watch Rising search interest for 'radiopharma automation' suggests increasing industry awareness and potential demand for ATS's specialized solutions in this high-growth segment.
Confidence: high
Paid Alt Data Watch
1. IQVIA — Pharmaceutical Sales Data
Matchediqvia_prescription_rx_data · access=file · map_only
Metric/field Global GLP-1 Drug Sales Volume (Units) by Drug and Region
Cadence monthly
Why it matters Provides granular, direct data on market adoption and commercial success of GLP-1 drugs, indicating demand for peptide APIs and delivery systems supplied by theme companies, including ATS's automation for fill-finish.
Signal to watch Consistent growth in GLP-1 sales volumes across key regions confirms sustained demand for manufacturing capacity and automation.
Confidence: high
2. Industrial Info Resources — Project Spending Database
Not in registry
Metric/field Capital Project Announcements/Status in Life Sciences, Nuclear, Food & Beverage sectors (by value and stage)
Cadence daily
Why it matters ATS's business is project-based, and tracking capital project announcements provides early indicators of future demand for automation solutions in its core end markets.
Signal to watch An increasing number and value of new capital project announcements, or projects advancing to later stages, signals a robust pipeline for ATS's services.
Confidence: high
3. Engineering News-Record (ENR) — Construction Cost Benchmark
Matchedengineering_news_record_construction_cost_benchmark · access=file · map_only
Metric/field Construction Cost Index (CCI)
Cadence monthly
Why it matters Construction costs impact the overall capital expenditure for new facilities (e.g., nuclear plants, pharma factories) where ATS installs its automation, affecting project budgets and feasibility.
Signal to watch Stable or moderately increasing CCI suggests a predictable cost environment for large-scale projects, while sharp increases could impact customer investment decisions.
Confidence: high
4. Dell'Oro Group — Data Center Infrastructure Market Research
Matched (medium)dell_oro_group_market_forecasts_technology_adoption · access=file · map_only
Metric/field Global Data Center Infrastructure Spending (Year-over-Year Growth)
Cadence quarterly
Why it matters ATS's energy segment is supported by investment in new power generation for data centers. This metric directly tracks capital spending in this growing end market.
Signal to watch Sustained growth in data center infrastructure spending indicates continued demand for power generation and associated automation, benefiting ATS's energy business.
Confidence: high
5. Norstella — Market / Industry Research (e.g., EvaluatePharma, MMIT)
Matchednorstella_drug_forecasts_commercial_intelligence · access=file · map_only
Metric/field Pipeline status and commercialization timelines for novel radiopharmaceutical therapies
Cadence quarterly
Why it matters Radiopharma is a key growth area for ATS. Tracking the pipeline and commercialization of new therapies provides insight into future demand for specialized automation and containment solutions.
Signal to watch An increasing number of radiopharma therapies advancing through clinical stages and nearing commercialization signals a growing market for ATS's equipment and services.
Confidence: medium
Search Keywords Brand Product
- SuperTrak
- Comecer
- IWK packaging
- radiopharma automation
- SMR manufacturing
- packaging automation equipment
- automation solutions
- manufacturing systems
- life sciences automation
- nuclear energy automation
- fixed cost transformation program
- aftermarket services
- industrial automation
Search Keywords Event Phrases
- ATS Q2 earnings
- ATS fiscal 2027 results
Search Keywords Policy Regulatory
- Section 38 tariffs
- trade talks Canada US
- What They Do (Plain English & Analogies)
- ATS Corporation is like a specialized factory builder and outfitter for companies that make complex products. Imagine a car manufacturer needing a highly precise robotic arm to assemble engine parts, or a pharmaceutical company needing a sterile, automated line to fill medicine vials. ATS designs, builds, installs, and maintains these custom-made, high-tech machines and entire production lines. They help businesses automate their manufacturing processes, from the initial planning and design to the ongoing maintenance and upgrades, ensuring efficiency, quality, and reliability, especially in highly regulated industries.
- Very Brief History
- Founded in Cambridge, Ontario, Canada, in 1978 by Klaus Woerner, ATS Corporation began as a machine builder. Over the decades, it expanded significantly through strategic acquisitions, including Sortimat Group (life sciences automation) in 2011, IWK (packaging) in 2013, M+W Group's automation business in 2014, Comecer S.p.A (isolation technology) in 2019, Avidity Science (biomedical research equipment) in 2023, and Heidolph Group (laboratory solutions) in 2024. Doug Wright was appointed CEO in December 2025, initiating a comprehensive portfolio review and fixed cost transformation program in fiscal 2027.
- "Street Stereotype"
- ATS.TO is currently perceived by investors and analysts as a company undergoing a significant operational transformation. The 'street' is focused on its ability to execute an 18-month fixed cost reduction program and achieve its stated operating margin target of 15% (and potentially higher), while simultaneously investing in and capitalizing on high-growth, regulated markets like radiopharmaceuticals and nuclear energy. There's an expectation that the company is shedding lower-margin activities, such as large-scale automotive work, to become a more profitable and focused automation leader in specialized, high-value segments. However, recent Q2 fiscal 2027 results, including a net loss and the withdrawal of full-year guidance, have added pressure on the company to demonstrate successful execution and a strong recovery.
- Subsidiaries On Linked In*
- ATS Life Sciences Systems — Division focused on life sciences automation
- Comecer — Manufacturer of isolation technology solutions
- BioDot — Life sciences dispensing technology
- Scientific Products Inc. — Laboratory equipment and solutions
- IWK — German packaging firm
- CFT — Processing and packaging for food and beverage
- Raytec — Optical sorting and X-ray inspection machines
- Co.Mac — Beverage filling and packaging
- Siapi — Linear blow molding machines for PET containers
- Paxiom Group — Provider of primary, secondary, and end-of-line packaging machines
- WeighPack Systems — Part of Paxiom Group, weighing, filling, bagging, wrapping machines
- EndFlex — Part of Paxiom Group, end-of-line packaging
- NCC Automated Systems — Part of Paxiom Group, conveyors
- Marco Limited — Weighing, filling, bagging, wrapping machines
- KangDi — Packaging machines
- Advanced Applications GmbH — German subsidiary
- Process Automation Solutions NV — Belgian subsidiary
- Hsg Engineering Srl — Italian subsidiary
- IPCOS Engineering Solutions Private Limited — Indian subsidiary
- Avidity Science — Biomedical research and life sciences water purification equipment
- Heidolph Group — Laboratory solutions provider
- Customer Sectors & Example Clients
- ATS Corporation serves a diverse range of customer sectors, including life sciences (medical devices, pharmaceuticals, radiopharmaceuticals, chemicals), food & beverage (processing, packaging, filling), energy (oil & gas, nuclear, solar, data centers), industrial & consumer products (warehousing automation, cosmetics, electronics, durable goods, telecommunications, semiconductor, fiber optics, computers), and transportation (electric vehicles, automotive, aerospace). Specific clients mentioned include an existing SMR (Small Modular Reactor) customer, a ZYN order with a new customer in nuclear, and customers involved in CANDU reactor refurbishment and life extension programs. In life sciences, they serve customers in areas like diabetes and vision care, automated pharmacy, automated sterilization, and liquid pharma visual inspection.
- New Customers / Segments They'Re Targeting
- ATS is actively targeting new customer segments by diversifying its pipeline, particularly within life sciences. This includes expanding into various medical device solutions such as diabetes and vision care, along with automated pharmacy and other evolving applications like automated sterilization and liquid pharma visual inspection. In the nuclear market, they are targeting new build opportunities, including Small Modular Reactors (SMRs), and are building capabilities in this area. Within their industrial business, ATS is broadening its pipeline into mission-critical production environments.
- Sales Geographies And Expansion Plans
- ATS Corporation has a significant global footprint with operations in over 25 countries, including numerous manufacturing facilities and offices across North America (Canada, United States), Europe (Germany, Italy, United Kingdom, Belgium, other European regions), Asia (India, Southeast Asia), and Oceania. The company plans to expand facilities in the US to support its growing nuclear business. The UK is also a target market for nuclear expansion. Additionally, its Comecer business (a subsidiary) has made significant investments in the US and recently commissioned a new service center in Melbourne, Australia, to support radiopharma research and development.
- How Key Themes May Help/Hurt
- The primary theme, 'GLP-1 Long '24: Peptide Manufacturing, Fill-Finish & Drug Delivery,' presents both opportunities and challenges for ATS. The company designs automated production equipment, including sterile filling, device assembly, inspection, and packaging systems, which are crucial for the high-volume manufacturing of injectable GLP-1 medicines. While ATS has supported GLP-1 customers and believes in the long-term growth of this market, the second quarter of fiscal 2027 saw a 'more normalized level of GLP-1-related volume' compared to the prior year, contributing to an 8.6% year-over-year revenue decline. This indicates that while the long-term demand for GLP-1 manufacturing capacity is a significant tailwind, short-term fluctuations in large orders can impact ATS's revenue performance.
3 Main Long-Term Bull Details
- Strong Growth in Regulated Markets: ATS is experiencing robust growth opportunities in regulated markets, particularly radiopharma, which achieved its highest order backlog in company history, and nuclear energy, driven by investments in energy security, infrastructure modernization, and new power generation for data centers, including Small Modular Reactors (SMRs).
- Fixed Cost Transformation Program: The company has initiated a comprehensive 18-month fixed cost transformation program, targeting $65 million to $75 million in annualized net savings. This program is designed to simplify operations, optimize its global footprint, and structurally lower the cost base, aiming to drive operating margins above 15%.
- Expanding Aftermarket Services and Innovation: ATS continues to focus on growing its higher-margin aftermarket services, which contributed to revenue growth in Q2 fiscal 2027. The strategic application of AI is also creating opportunities as both a demand driver and a capability, enhancing ATS's solutions and deep domain expertise across all end markets.
3 Main Long-Term Bear Details
- Short-Term Revenue and Earnings Softness: ATS experienced a soft Q2 fiscal 2027, with adjusted revenues down 8.6% year-over-year and adjusted earnings from operations down 27.4%. The company reported a net loss of $5.0 million and withdrew its previous fiscal 2027 guidance for modest revenue growth and margin expansion, citing temporary delays in order bookings due to Section 38 tariffs and the execution time for orders to convert to revenues.
- Lumpiness in Order Bookings and Project Execution: The markets ATS serves, particularly those involving new science or major regulatory criteria like nuclear and radiopharma, are inherently lumpy in the short cycle. This can lead to volatility in order rates and project awards, making near-term revenue and earnings forecasts challenging, even with a healthy long-term demand.
- Execution Risk of Transformation Program: While the fixed cost transformation program is expected to yield significant savings, its full implementation and realization of benefits are anticipated to occur over several quarters. The program involves workforce reductions and facility closures, and the company expects temporary offsets to benefits from lower revenues and mix in the near term.
- Competitors And Differentiation
- ATS's top competitors include Eclipse Automation, Brock Solutions, and Prodomax Automation. Other notable competitors in the broader automation space include Emerson Electric Co., Rockwell Automation, Inc., Cognex Corporation, Keyence Corporation, ABB Ltd, and Siemens AG. ATS differentiates itself as a specialized integrator and builder of custom, turnkey automated manufacturing systems, contrasting with larger competitors who often focus on selling standardized hardware and software products. The company leverages its deep technical expertise, strong customer relationships, and differentiated capabilities in highly regulated environments, such as containment and automation for radiopharma, to solve complex scientific and manufacturing problems. Their ATS Business Model also drives internal efficiency and commercial process acumen.
- Recent Performance & What The Market'S Focused On
- ATS Corporation reported its second-quarter fiscal 2027 results with strong order bookings of $827 million, up 12.7% year-over-year, driven by life sciences, which achieved its highest order backlog on record at $1.2 billion. However, revenues were $665.8 million, an 8.6% decrease year-over-year, and the company posted a net loss of $5.0 million. Adjusted earnings from operations were $57.4 million, with an adjusted margin of 8.6%, down from 10.9% in the prior year, primarily due to lower volumes and an unfavorable mix. Cash flow from operating activities significantly improved to $81 million. The company withdrew its previous fiscal 2027 guidance for modest revenue growth and margin expansion, citing temporary delays in order bookings, particularly in packaging automation equipment due to Section 38 tariffs, and the execution time for orders to convert to revenues. The market is currently focused on the impact of the resolved Section 38 tariffs on future order bookings, the pace at which the record life sciences backlog will convert into revenue, the successful implementation and realization of the $65 million to $75 million in annualized savings from the fixed cost transformation program, and the company's ability to return to top-line growth and margin improvement.
- Revenue Segments And Estimated Mix
- {"segments":[{"segment_name":"Life Sciences","estimated_mix":"~46.9% (FY2023)","source_or_comment":"FY2023 filing, Q2 FY2027 transcript","yoy_or_trend_comment":"Highest backlog on record ($1.2 billion) in Q2 FY27, strong opportunity funnel, particularly in radiopharma, trailing 12-month book-to-bill (ex-GLP-1) ~1.1x."},{"segment_name":"Transportation","estimated_mix":"~22.4% (FY2023)","source_or_comment":"FY2023 filing, Q1 FY2027 transcript","yoy_or_trend_comment":"Planned reduction in large-scale automotive work."培養},{"segment_name":"Food & Beverage","estimated_mix":"~14.4% (FY2023)","source_or_comment":"FY2023 filing, Q2 FY2027 transcript","yoy_or_trend_comment":"Backlog was $223 million in Q2 FY27, bookings up year over year for the third consecutive quarter but below expectations for the year based on cyclicality in the tomato business."},{"segment_name":"Consumer Products","estimated_mix":"~11.8% (FY2023)","source_or_comment":"FY2023 filing"},{"segment_name":"Energy","estimated_mix":"~4.4% (FY2023)","source_or_comment":"FY2023 filing, Q2 FY2027 transcript","yoy_or_trend_comment":"Backlog was $236 million in Q2 FY27, funnel remains strong, supported by investment in energy security, infrastructure modernization, and new power generation for data centers."},{"segment_name":"Industrial and Consumer","estimated_mix":"n/m","source_or_comment":"Q2 FY2027 transcript","yoy_or_trend_comment":"Backlog was $312 million in Q2 FY27, funnel activity stable, repositioning portfolio toward opportunities with better returns, broadening pipeline into mission-critical production environments."},{"segment_name":"Services (Aftermarket)","estimated_mix":"n/m","source_or_comment":"Q2 FY2027 transcript","yoy_or_trend_comment":"Grew in Q2 FY27, focus on this longer-term margin accretion driver."},{"segment_name":"Combined Life Sciences, Food & Beverage, and Energy","estimated_mix":"~85% of total backlog","source_or_comment":"Q2 FY2027 transcript","yoy_or_trend_comment":"Represented more than 85% of total backlog in Q2 FY27."}]}
- Product Brands
- SuperTrak
- Illuminate
- IWK
- CFT
- Raytec
- Co.Mac
- Siapi
- Paxiom
- WeighPack
- EndFlex
- NCC
- Marco
- KangDi
- Comecer
- BioDot
- Scientific Products Inc.